Business Context and Reporting Period
This Form 8-K is filed by Ra Medical Systems, Inc. (not Catheter Precision, Inc.) on November 29, 2019. The report serves to announce the Company's financial results for the three and nine months ended September 30, 2019. The registrant is an emerging growth company incorporated in Delaware, with its principal executive offices in Carlsbad, California.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not reproduced in the body of this 8-K.
Material Changes
The filing does not detail specific material changes versus prior periods. It solely references the issuance of a press release containing the comparative financial results for the three and nine months ended September 30, 2019.
Guidance, Outlook, and Risks
The text does not include specific guidance, outlook, management commentary, or risk factors. It notes that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other documents unless expressly stated.
Investor Verification Checklist
- Verify the correct registrant name is Ra Medical Systems, Inc. (Ticker: RMED), not Catheter Precision, Inc.
- Review Exhibit 99.1 (the press release) for actual financial figures, as they are absent from the 8-K text.
- Confirm the reporting period covers the three and nine months ended September 30, 2019.
- Note that the report was signed by Andrew Jackson, Interim Chief Executive Officer and Chief Financial Officer.